Sara Medved
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sara Medved has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
- Cristiana Tapoi
Department of General Psychiatry, Alexandru Obregia Clinical Psychiatry Hospital, 041902 Bucharest, Romania
2 shared publications - Mariana Pinto da Costa
South London and Maudsley NHS Foundation Trust
2 shared publications Miloš Milutinović
University Clinic of Psychiatry
2 shared publications- Renato de Filippis
Psychiatry Unit, Department of Health Sciences, University Magna Graecia of Catanzaro, Catanzaro, Italy
2 shared publications Adlin Pinheiro
Department of Biostatistics, Boston University School of Public Health; Boston, Massachusetts 02118, United States
1 shared publication- Agorastos Agorastos
Aristotle University of Thessaloniki, II. Dept. of Psychiatry, Medical School, Faculty of Health Sciences, Thessaloniki, Greece
1 shared publication
Latest Publications
- Open Access
- 13 February 2026
- Published by Royal College of Psychiatrists in European Psychiatry
- Vol. 69 (1) , 1-21
Indirect, machine learning-based suicide risk screening: Evidence from cross-National Validation
Background: Suicide is a major public health challenge requiring early detection of suicidal ideation (SI). Traditional direct questioning methods suffer from stigma and disclosure bias, failing to identify many at-risk individuals. While machine learning (ML) models show promise, most lack external validation. Indirect screening, using psychosocial data rather than direct SI questions, offers a scalable alternative. This study aimed to externally validate an indirect, ML-based SI screening tool. We tested if a model trained on a Slovenian general population sample retained predictive accuracy when applied to an independent Croatian sample during a period of societal stress (pandemic and earthquakes), assessing performance across age and gender subgroups. Methods: A logistic regression model was trained on a Slovenian sample ( N = 2,989) and validated on a Croatian sample ( N = 2,364). The model used only indirect predictors, including sociodemographics, life satisfaction, behavioral changes, and Brief COPE subscales. The target outcome was the presence of SI (SIDAS score > 0). Performance was measured by the area under the receiver operating characteristic curve (AUROC). Results: The model demonstrated strong external validity on the entire Croatian sample, achieving an AUROC of 0.80. Performance remained robust across subgroups: males (AUROC = 0.83), females (AUROC = 0.79), younger adults (AUROC = 0.77), and older adults (AUROC = 0.81). Self-blame, behavioral disengagement, and relationship dissatisfaction were key predictors. Conclusions: An indirect, ML-based screening tool can reliably identify SI risk in the general population. The model demonstrated strong cross-national transferability and resilience during a societal crisis, proving it is a feasible and valid strategy for population-level prevention.
- 13 February 2026
- Published by Royal College of Psychiatrists in European Psychiatry
- Vol. 69 (1) , 1-21
Open AccessIndirect, machine learning-based suicide risk screening: Evidence from cross-National Validation
Background: Suicide is a major public health challenge requiring early detection of suicidal ideation (SI). Traditional direct questioning methods suffer from stigma and disclosure bias, failing to identify many at-risk individuals. While machine learning (ML) models show promise, most lack external validation. Indirect screening, using psychosocial data rather than direct SI questions, offers a scalable alternative. This study aimed to externally validate an indirect, ML-based SI screening tool. We tested if a model trained on a Slovenian general population sample retained predictive accuracy when applied to an independent Croatian sample during a period of societal stress (pandemic and earthquakes), assessing performance across age and gender subgroups. Methods: A logistic regression model was trained on a Slovenian sample ( N = 2,989) and validated on a Croatian sample ( N = 2,364). The model used only indirect predictors, including sociodemographics, life satisfaction, behavioral changes, and Brief COPE subscales. The target outcome was the presence of SI (SIDAS score > 0). Performance was measured by the area under the receiver operating characteristic curve (AUROC). Results: The model demonstrated strong external validity on the entire Croatian sample, achieving an AUROC of 0.80. Performance remained robust across subgroups: males (AUROC = 0.83), females (AUROC = 0.79), younger adults (AUROC = 0.77), and older adults (AUROC = 0.81). Self-blame, behavioral disengagement, and relationship dissatisfaction were key predictors. Conclusions: An indirect, ML-based screening tool can reliably identify SI risk in the general population. The model demonstrated strong cross-national transferability and resilience during a societal crisis, proving it is a feasible and valid strategy for population-level prevention.
- Open Access
- 17 December 2025
- Published by Royal College of Psychiatrists in European Psychiatry
- Vol. 69 (1) , 1-26
Early career psychiatrists’ ability to evaluate and manage negative symptoms of schizophrenia – Results from a European survey
Background: Negative symptoms (NS) represent an important unmet need in schizophrenia (SZ) assessment and management. Despite NS are strongly associated with poorer functioning and quality of life, they are frequently underrecognized, inconsistently evaluated, and show limited response to current treatments. Although specific assessment tools and European Psychiatric Association (EPA) guidance on NS have been developed, their impact on routine clinical practice appears limited. This study aimed to investigate the competence and confidence of European Early Career Psychiatrists (ECPs) in NS evaluation and management. Methods: The CARE project was a cross-sectional online survey directed towards ECPs from European countries. Results: 828 ECPs’ responses were collected from 19 countries. The majority of ECPs were trainees (65.8%), reported theoretical training in negative symptoms (NS) and placements in schizophrenia-specialized settings (67.9% and 70.3%), while about half reported extracurricular NS training (51.1%) and involvement in clinical research (46.1%). Only 11% correctly identified NS domains, despite 65.7% felt well-trained in NS assessment tools. Just 15.9% correctly answered questions based on the EPA guidance papers. 46.7% and 25.9% ECPs reported feeling competent in NS evaluation and management, respectively. Gender (men) specialist status, research involvement, theoretical NS training, and placements in specialized SZ services predicted perceived competence. However, in-depth NS knowledge was predicted only by specialist status, engagement in clinical research, and extracurricular NS training. Conclusions: Despite reported exposure to NS training, ECPs demonstrated limited knowledge of NS. Actions need to be taken to ensure that ECPs receive the highest standard of training in NS.
- 17 December 2025
- Published by Royal College of Psychiatrists in European Psychiatry
- Vol. 69 (1) , 1-26
Open AccessEarly career psychiatrists’ ability to evaluate and manage negative symptoms of schizophrenia – Results from a European survey
Background: Negative symptoms (NS) represent an important unmet need in schizophrenia (SZ) assessment and management. Despite NS are strongly associated with poorer functioning and quality of life, they are frequently underrecognized, inconsistently evaluated, and show limited response to current treatments. Although specific assessment tools and European Psychiatric Association (EPA) guidance on NS have been developed, their impact on routine clinical practice appears limited. This study aimed to investigate the competence and confidence of European Early Career Psychiatrists (ECPs) in NS evaluation and management. Methods: The CARE project was a cross-sectional online survey directed towards ECPs from European countries. Results: 828 ECPs’ responses were collected from 19 countries. The majority of ECPs were trainees (65.8%), reported theoretical training in negative symptoms (NS) and placements in schizophrenia-specialized settings (67.9% and 70.3%), while about half reported extracurricular NS training (51.1%) and involvement in clinical research (46.1%). Only 11% correctly identified NS domains, despite 65.7% felt well-trained in NS assessment tools. Just 15.9% correctly answered questions based on the EPA guidance papers. 46.7% and 25.9% ECPs reported feeling competent in NS evaluation and management, respectively. Gender (men) specialist status, research involvement, theoretical NS training, and placements in specialized SZ services predicted perceived competence. However, in-depth NS knowledge was predicted only by specialist status, engagement in clinical research, and extracurricular NS training. Conclusions: Despite reported exposure to NS training, ECPs demonstrated limited knowledge of NS. Actions need to be taken to ensure that ECPs receive the highest standard of training in NS.
- 1 September 2025
- Published by Wolters Kluwer Health in Neurology Open Access
- Vol. 1 (3)
Association of MRI-Visible Perivascular Spaces and Incident Depression in the Framingham Heart Study
- 1 September 2025
- Published by Wolters Kluwer Health in Neurology Open Access
- Vol. 1 (3)
Association of MRI-Visible Perivascular Spaces and Incident Depression in the Framingham Heart Study
- 6 June 2024
- Published by Wiley in Psychiatry and Clinical Neurosciences
- Vol. 78 (8) , 438-445
The association between levels of brain‐derived neurotrophic factor and comorbid depression in patients with cardiovascular disease: The Framingham Heart Study
Aim: The current study aims to investigate the association of serum brain‐derived neurotrophic factor (BDNF) levels with symptoms of depression in adults with and without prevalent cardiovascular disease (CVD), an often burdensome comorbidity.Methods: This cross‐sectional study included participants from FHS (Framingham Heart Study) who had available serum BDNF levels. Depressive symptoms were assessed using the Center for Epidemiological Studies–Depression Scale (CES‐D) with a score ≥16 indicating mild to moderate and ≥21 severe depression. Participants taking antidepressant medications were excluded from the study.Results: Altogether 3716 FHS participants were included in the final analysis (mean age, 64.3 ± 11.5 years; 55% women). After adjusting for potential confounders, greater BDNF levels were associated with reduced severe depression risk (odds ratio [OR], 0.78 [95% CI, 0.64–0.96]; P = 0.016). Among participants with CVD, greater BDNF levels were related to lower risk of depressive symptoms (CES‐D ≥ 16 OR, 0.63 [95% CI, 0.45–0.89], P = 0.008; CES‐D ≥ 21 OR, 0.49 [95% CI, 0.31–0.76], P = 0.002). The inverse relationship between BDNF and depressive symptom risk was present in women with CVD (CES‐D ≥ 16 OR, 0.63 [95% CI, 0.40–0.99], P = 0.047; CES‐D ≥ 21 OR, 0.38 [95% CI, 0.21–0.70], P = 0.002) but not in men.Conclusion: Lower serum BDNF levels are associated with a higher risk of depressive symptoms in CVD, particularly among women. These findings implicate BDNF in the complex biological mechanisms that underlie prior associations observed between CVD and depression. To reduce the burden of depression in the large proportion of midlife and older adults with CVD, a better understanding of how BDNF may modify these pathways is merited.
- 6 June 2024
- Published by Wiley in Psychiatry and Clinical Neurosciences
- Vol. 78 (8) , 438-445
The association between levels of brain‐derived neurotrophic factor and comorbid depression in patients with cardiovascular disease: The Framingham Heart Study
Aim: The current study aims to investigate the association of serum brain‐derived neurotrophic factor (BDNF) levels with symptoms of depression in adults with and without prevalent cardiovascular disease (CVD), an often burdensome comorbidity.Methods: This cross‐sectional study included participants from FHS (Framingham Heart Study) who had available serum BDNF levels. Depressive symptoms were assessed using the Center for Epidemiological Studies–Depression Scale (CES‐D) with a score ≥16 indicating mild to moderate and ≥21 severe depression. Participants taking antidepressant medications were excluded from the study.Results: Altogether 3716 FHS participants were included in the final analysis (mean age, 64.3 ± 11.5 years; 55% women). After adjusting for potential confounders, greater BDNF levels were associated with reduced severe depression risk (odds ratio [OR], 0.78 [95% CI, 0.64–0.96]; P = 0.016). Among participants with CVD, greater BDNF levels were related to lower risk of depressive symptoms (CES‐D ≥ 16 OR, 0.63 [95% CI, 0.45–0.89], P = 0.008; CES‐D ≥ 21 OR, 0.49 [95% CI, 0.31–0.76], P = 0.002). The inverse relationship between BDNF and depressive symptom risk was present in women with CVD (CES‐D ≥ 16 OR, 0.63 [95% CI, 0.40–0.99], P = 0.047; CES‐D ≥ 21 OR, 0.38 [95% CI, 0.21–0.70], P = 0.002) but not in men.Conclusion: Lower serum BDNF levels are associated with a higher risk of depressive symptoms in CVD, particularly among women. These findings implicate BDNF in the complex biological mechanisms that underlie prior associations observed between CVD and depression. To reduce the burden of depression in the large proportion of midlife and older adults with CVD, a better understanding of how BDNF may modify these pathways is merited.
- Open Access
- 1 January 2024
- Published by Royal College of Psychiatrists in European Psychiatry
- Vol. 67 (1) , e86
Early career psychiatrists’ perceptions of and training experience in electroconvulsive therapy: A cross-sectional survey across Europe
Background: Electroconvulsive therapy (ECT) is a safe and effective treatment for several major psychiatric conditions, including treatment-resistant depression, mania, and schizophrenia; nevertheless, its use remains controversial. Despite its availability in some European countries, ECT is still rarely used in others. This study aims to investigate the experiences and attitudes of early career psychiatrists (ECPs) across Europe towards ECT and to examine how their exposure to ECT influences their perceptions. Methods: In Europe, a cross-sectional survey was conducted among ECPs, including psychiatric trainees and recently fully qualified psychiatrists. Results: A total of 573 participants from 30 European countries were included in the study, of whom more than half (N = 312; 54.5%) received ECT training. Overall, ECPs had a positive attitude towards ECT, with the vast majority agreeing or strongly agreeing that ECT is an effective (N = 509; 88.8%) and safe (N = 464; 81.0%) treatment and disagreeing or strongly disagreeing that ECT was used as a form of control or punishment (N = 545; 95.1%). Those who had received ECT training during their psychiatry training were more likely to recommend ECT to their patients (p < 0.001, r = 0.34), and held more positive views on its safety (p < 0.001, r = 0.31) and effectiveness (p < 0.001, r = 0.33). Interest in further education about ECT was moderately high (modal rating on Likert scale: 4, agree), irrespective of prior training exposure. Conclusions: ECT training is associated with more favorable perceptions of its safety and effectiveness among ECPs. There is a general willingness among ECPs to expand their knowledge and training on ECT, which could enhance patients’ access to this treatment.
- 1 January 2024
- Published by Royal College of Psychiatrists in European Psychiatry
- Vol. 67 (1) , e86
Open AccessEarly career psychiatrists’ perceptions of and training experience in electroconvulsive therapy: A cross-sectional survey across Europe
Background: Electroconvulsive therapy (ECT) is a safe and effective treatment for several major psychiatric conditions, including treatment-resistant depression, mania, and schizophrenia; nevertheless, its use remains controversial. Despite its availability in some European countries, ECT is still rarely used in others. This study aims to investigate the experiences and attitudes of early career psychiatrists (ECPs) across Europe towards ECT and to examine how their exposure to ECT influences their perceptions. Methods: In Europe, a cross-sectional survey was conducted among ECPs, including psychiatric trainees and recently fully qualified psychiatrists. Results: A total of 573 participants from 30 European countries were included in the study, of whom more than half (N = 312; 54.5%) received ECT training. Overall, ECPs had a positive attitude towards ECT, with the vast majority agreeing or strongly agreeing that ECT is an effective (N = 509; 88.8%) and safe (N = 464; 81.0%) treatment and disagreeing or strongly disagreeing that ECT was used as a form of control or punishment (N = 545; 95.1%). Those who had received ECT training during their psychiatry training were more likely to recommend ECT to their patients (p < 0.001, r = 0.34), and held more positive views on its safety (p < 0.001, r = 0.31) and effectiveness (p < 0.001, r = 0.33). Interest in further education about ECT was moderately high (modal rating on Likert scale: 4, agree), irrespective of prior training exposure. Conclusions: ECT training is associated with more favorable perceptions of its safety and effectiveness among ECPs. There is a general willingness among ECPs to expand their knowledge and training on ECT, which could enhance patients’ access to this treatment.